2308035-51-8 (Thalidomide-O-amido-C3-COOH,Thalidomide-O-amido-C3-COOH)

Thalidomide-O-amido-C3-COOH;Thalidomide-O-amido-C3-carboxylic acid;E3 Ligase Ligand-Linker Conjugates 15;4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butanoic acid;Thalidomide-O-amido-C3-carboxylic acid;Cereblon Ligand-Linker Conjugates 7; E3 ligase Ligand-Linker Conjugates 15;4-[[2-[2-(2,6-dioxo-3-piperidyl)-1,3-dioxo-isoindolin-4-yl]oxyacetyl]amino]butanoic acid;4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butanoic acid;2308035-51-8;AT18332;HY-103612;CS-7754;Thalidomide-O-acetamido-C3-acid;4-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy}acetamido)butanoic acid;BCP33437;AKOS037653310;SCHEMBL23636449;A1-29431;EX-A3942;

MFCD31560483

RZVLFEVSXBBCIP-UHFFFAOYSA-N

1S/C19H19N3O8/c23-13-7-6-11(17(27)21-13)22-18(28)10-3-1-4-12(16(10)19(22)29)30-9-14(24)20-8-2-5-15(25)26/h1,3-4,11H,2,5-9H2,(H,20,24)(H,25,26)(H,21,23,27)

O(C([H])([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H])=O)C1=C([H])C([H])=C([H])C2=C1C(N(C2=O)C1([H])C(N([H])C(C([H])([H])C1([H])[H])=O)=O)=O